Israel Englander’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.2K Buy
+31,995
New +$98.4K ﹤0.01% 5505
2024
Q1
Sell
-469
Closed -$18.7K 6239
2023
Q4
$18.7K Buy
469
+102
+28% +$3.6K ﹤0.01% 5646
2023
Q3
$11.7K Sell
367
-4
-1% -$151 ﹤0.01% 5742
2023
Q2
$12.4K Sell
371
-3
-0.8% -$115 ﹤0.01% 5727
2023
Q1
$17K Sell
374
-611
-62% -$49K ﹤0.01% 5906
2022
Q4
$74K Sell
985
-1,077
-52% -$101K ﹤0.01% 5669
2022
Q3
$199K Sell
2,062
-3,419
-62% -$478K ﹤0.01% 5668
2022
Q2
$922K Sell
5,481
-6,968
-56% -$1.06M ﹤0.01% 4436
2022
Q1
$2.31M Sell
12,449
-6,126
-33% -$1.27M ﹤0.01% 3743
2021
Q4
$4.98M Sell
18,575
-6,575
-26% -$1.72M ﹤0.01% 2911
2021
Q3
$7.34M Buy
25,150
+10,235
+69% +$2.99M ﹤0.01% 2425
2021
Q2
$3.69M Buy
+14,915
New +$3.83M ﹤0.01% 3162
2021
Q1
Sell
-2,133
Closed -$595K 5994
2020
Q4
$595K Buy
2,133
+352
+20% +$130K ﹤0.01% 4070
2020
Q3
$726 Buy
1,781
+727
+69% +$373K ﹤0.01% 3353
2020
Q2
$612K Sell
1,054
-2,406
-70% -$1.1M ﹤0.01% 3282
2020
Q1
$791K Buy
+3,460
New +$600K ﹤0.01% 2609
2018
Q1
Sell
-482
Closed -$38K 3689
2017
Q4
$38K Sell
482
-2,060
-81% -$308K ﹤0.01% 3731
2017
Q3
$477K Buy
+2,542
New +$388K ﹤0.01% 2862

Other funds holding CODX

Israel Englander's CODX Position: Q2 2026 in Review

Israel Englander opened a new position in Co-Diagnostics (CODX) in Q2 2026: 31,995 shares worth $99.2K. The stake represents ﹤0.01% of the portfolio and ranks #5505 among its holdings. This is a return to the name: Israel Englander previously reported a position in CODX as recently as Q4 2023.

Israel Englander first reported a position in CODX in Q3 2017 and has held it in 18 quarters since. The position peaked at $7.34M in Q3 2021. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

  • Israel Englander held 31,995 shares of Co-Diagnostics worth $99.2K as of Q2 2026.
  • Co-Diagnostics was a new Israel Englander position in Q2 2026.
  • Co-Diagnostics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5505 holding.
  • Israel Englander first reported a position in Co-Diagnostics in Q3 2017 and has held it in 18 quarters since.
  • Israel Englander's Co-Diagnostics position peaked at $7.34M in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.